Myriad Asset Management US LP Purchases Shares of 6,045 SPDR S&P Biotech ETF $XBI

Myriad Asset Management US LP purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, HoldingsChannel reports. The fund purchased 6,045 shares of the exchange traded fund’s stock, valued at approximately $737,000. SPDR S&P Biotech ETF makes up about 1.2% of Myriad Asset Management US LP’s holdings, making the stock its 18th largest holding.

A number of other institutional investors have also modified their holdings of XBI. JPMorgan Chase & Co. grew its position in shares of SPDR S&P Biotech ETF by 27.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Bessemer Group Inc. lifted its position in SPDR S&P Biotech ETF by 9.3% during the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after acquiring an additional 138,322 shares during the last quarter. Ameriprise Financial Inc. lifted its position in SPDR S&P Biotech ETF by 40.5% during the third quarter. Ameriprise Financial Inc. now owns 1,226,147 shares of the exchange traded fund’s stock valued at $122,906,000 after acquiring an additional 353,351 shares during the last quarter. Meitav Investment House Ltd. boosted its stake in SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock valued at $68,156,000 after acquiring an additional 281,602 shares in the last quarter. Finally, Greenhouse Funds LLLP boosted its stake in SPDR S&P Biotech ETF by 16.6% in the third quarter. Greenhouse Funds LLLP now owns 675,975 shares of the exchange traded fund’s stock valued at $67,733,000 after acquiring an additional 96,308 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $128.96 on Friday. The firm’s fifty day simple moving average is $125.00 and its two-hundred day simple moving average is $118.38. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $132.09. The firm has a market capitalization of $7.51 billion, a P/E ratio of 11.47 and a beta of 0.93.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.